Mallinckrodt PLC (NYSE:MNK) Expected to Announce Earnings of $2.02 Per Share
Brokerages predict that Mallinckrodt PLC (NYSE:MNK) will report earnings per share (EPS) of $2.02 for the current quarter, according to Zacks. Eight analysts have issued estimates for Mallinckrodt’s earnings. The lowest EPS estimate is $1.90 and the highest is $2.20. Mallinckrodt posted earnings per share of $2.10 in the same quarter last year, which suggests a negative year-over-year growth rate of 3.8%. The company is scheduled to announce its next quarterly earnings report on Tuesday, November 5th.
According to Zacks, analysts expect that Mallinckrodt will report full-year earnings of $8.41 per share for the current fiscal year, with EPS estimates ranging from $7.92 to $8.61. For the next year, analysts expect that the company will post earnings of $7.48 per share, with EPS estimates ranging from $5.55 to $8.51. Zacks’ EPS averages are a mean average based on a survey of analysts that that provide coverage for Mallinckrodt.
Mallinckrodt (NYSE:MNK) last posted its earnings results on Tuesday, August 6th. The company reported $2.53 EPS for the quarter, topping the consensus estimate of $2.10 by $0.43. The firm had revenue of $823.30 million for the quarter, compared to analyst estimates of $817.55 million. Mallinckrodt had a positive return on equity of 18.96% and a negative net margin of 111.46%. Mallinckrodt’s revenue for the quarter was down .3% compared to the same quarter last year. During the same period last year, the company earned $2.16 earnings per share.
MNK stock traded up $0.08 during mid-day trading on Wednesday, reaching $4.61. 3,122,821 shares of the company’s stock were exchanged, compared to its average volume of 2,786,082. The company has a market cap of $342.76 million, a price-to-earnings ratio of 0.58, a price-to-earnings-growth ratio of 0.04 and a beta of 2.29. The stock’s 50 day moving average is $6.77 and its 200 day moving average is $14.70. The company has a debt-to-equity ratio of 1.57, a current ratio of 0.78 and a quick ratio of 0.57. Mallinckrodt has a 12-month low of $3.85 and a 12-month high of $36.39.
In other news, CFO Bryan M. Reasons bought 5,400 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were acquired at an average price of $8.96 per share, for a total transaction of $48,384.00. Following the completion of the transaction, the chief financial officer now directly owns 17,979 shares in the company, valued at approximately $161,091.84. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 2.70% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MNK. Luminus Management LLC acquired a new stake in shares of Mallinckrodt in the second quarter valued at $3,144,000. Maverick Capital Ltd. acquired a new stake in shares of Mallinckrodt in the second quarter valued at $3,533,000. United Services Automobile Association boosted its holdings in Mallinckrodt by 6.0% in the second quarter. United Services Automobile Association now owns 146,300 shares of the company’s stock valued at $1,343,000 after purchasing an additional 8,246 shares during the period. Anderson Fisher LLC boosted its holdings in Mallinckrodt by 114.9% in the second quarter. Anderson Fisher LLC now owns 11,358 shares of the company’s stock valued at $104,000 after purchasing an additional 6,073 shares during the period. Finally, Clear Creek Financial Management LLC purchased a new position in Mallinckrodt in the second quarter valued at $209,000.
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.